Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment

被引:126
|
作者
Palepu, A
Horton, NJ
Tibbetts, N
Meli, S
Samet, JH
机构
[1] Univ British Columbia, St Pauls Hosp, Dept Med, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V5Z 1M9, Canada
[2] DM STAT Inc, Medford, MA USA
[3] Boston Univ, Sch Med, Northampton, MA USA
[4] Boston Univ, Sch Publ Hlth, Northampton, MA USA
[5] Smith Coll, Dept Math, Northampton, MA 01063 USA
[6] Boston Univ, Dept Med, Gen Internal Med Sect, CARE Unit, Vancouver, WA USA
[7] Boston Univ, Dept Social & Behav Sci, Vancouver, WA USA
关键词
access; adherence; alcohol; antiretroviral therapy; HIV; substance abuse treatment; substance use;
D O I
10.1111/j.1360-0443.2003.00670.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aim We examined the association of substance abuse treatment with uptake, adherence and virological response to highly active antiretroviral therapy (HAART) among HIV-infected people with a history of alcohol problems. Design Prospective cohort study. Methods A standardized questionnaire was administered to 349 HIV-infected participants with a history of alcohol problems regarding demographics, substance use, use of substance abuse treatment and uptake of and adherence to HAART. These subjects were followed every 6 months for up to seven occasions. We defined substance abuse treatment services as any of the following in the past 6 months: 12 weeks in a half-way house or residential facility; 12 visits to a substance abuse counselor or mental health professional; or participation in any methadone maintenance program. Our outcome variables were uptake of antiretroviral therapy, 30-day self-reported adherence and HIV viral load suppression. Findings At baseline, 59% (205/349) of subjects were receiving HAART. Engagement in substance abuse treatment was independently associated with receiving antiretroviral therapy (adjusted OR; 95% CI: 1.70; 1.03-2.83). Substance abuse treatment was not associated with 30-day adherence or HIV viral load suppression. More depressive symptoms (0.48; 0.32-0.78) and use of drugs or alcohol in the previous 30 days (0.17; 0.11-0.28) were associated with worse 30-day adherence. HIV viral load suppression was positively associated with higher doses of antiretroviral medication (1.29; 1.15-1.45) and older age (1.04; 1.00-1.07) and negatively associated with use of drugs or alcohol in the previous 30 days (0.51; 0.33-0.78). Conclusion Substance abuse treatment was associated with receipt of HAART; however, it was not associated with adherence or HIV viral load suppression. Substance abuse treatment programs may provide an opportunity for HIV-infected people with alcohol or drug problems to openly address issues of HIV care including enhancing adherence to HAART.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 50 条
  • [1] Highly active antiretroviral therapy among HIV-infected people with alcohol and substance misuse problems: The impact of substance abuse treatment
    O'Shea, J
    Keenan, E
    ADDICTION, 2004, 99 (08) : 1064 - 1065
  • [2] Substance abuse treatment and adherence to antiretroviral therapy among HIV-infected persons with alcohol problems.
    Palepu, A
    Horton, NJ
    Tibbetts, N
    Meli, S
    Samet, JH
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 184 - 185
  • [3] Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals
    Lucas, Gregory M.
    LIFE SCIENCES, 2011, 88 (21-22) : 948 - 952
  • [4] The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States
    Yuehan Zhang
    Tracey E. Wilson
    Adebola Adedimeji
    Daniel Merenstein
    Joel Milam
    Jennifer Cohen
    Mardge Cohen
    Elizabeth T. Golub
    AIDS and Behavior, 2018, 22 : 896 - 908
  • [5] The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States
    Zhang, Yuehan
    Wilson, Tracey E.
    Adedimeji, Adebola
    Merenstein, Daniel
    Milam, Joel
    Cohen, Jennifer
    Cohen, Mardge
    Golub, Elizabeth T.
    AIDS AND BEHAVIOR, 2018, 22 (03) : 896 - 908
  • [6] Distress Tolerance and Use of Antiretroviral Therapy Among HIV-Infected Individuals in Substance Abuse Treatment
    Magidson, Jessica F.
    Seitz-Brown, C. J.
    Listhaus, Alyson
    Lindberg, Briana
    Anderson, Katelyn E.
    Daughters, Stacey B.
    AIDS PATIENT CARE AND STDS, 2013, 27 (09) : 518 - 523
  • [7] Substance abuse treatment and hospitalization among a cohort of HIV-infected individuals with alcohol problems
    Palepu, A
    Horton, NJ
    Tibbetts, N
    Meli, S
    Samet, JH
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (03) : 389 - 394
  • [8] Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems
    Palepu, A
    Raj, A
    Horton, NJ
    Tibbetts, N
    Meli, S
    Samet, JH
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2005, 28 (01) : 3 - 9
  • [9] Substance abuse treatment and risk behaviors among HIV-infected persons with alcohol problems
    Palepu, A
    Raj, A
    Horton, NJ
    Tibbetts, N
    Meli, S
    Samet, JH
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (05) : 162A - 162A
  • [10] Association of Race, Substance Abuse, and Health Insurance Coverage With Use of Highly Active Antiretroviral Therapy Among HIV-Infected Women, 2005
    Lillie-Blanton, Marsha
    Stone, Valerie E.
    Jones, Alison Snow
    Levi, Jeffrey
    Golub, Elizabeth T.
    Cohen, Mardge H.
    Hessol, Nancy A.
    Wilson, Tracey E.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2010, 100 (08) : 1493 - 1499